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013.01.0Abstract Background: Cardiac complications, heart failure and arrhythmias remain the major
causes of death in thalassemia major.
Aim: To detect the early cardiac involvement in b-thalassemic patients.
Patients and methods: 56 Patients (pts) with b-thalassemia major and transfusion burden
P12 times/year (age 6–16 years) were included in our study, classiﬁed into three groups according
to serum ferritin, group I: 21 pts with ferritin level <2500 ng/ml, group II: 23 pts with ferritin level
2500–5000 and group III: 12 pts with ferritin level >5000 ng/ml. They were subjected to detailed
clinical evaluation, routine laboratory investigations, serum ferritin level, ECG {corrected QT inter-
vals (QTc) and QT dispersion(QTd)}, echocardiography for measurement of left atrial (LA) active
emptying fraction, Systolic (peak systolic wave, Q–S peak duration) and diastolic functions of left
ventricle using standard and tissue Doppler imaging (TDI).
Results: Groups III and II showed a signiﬁcant increase in LV septal and posterior wall thickness
than group I while QTc and QTd were increased signiﬁcantly only in group III compared to group I
(P= 0.00, 0.01). LV diastolic function and LA active emptying fraction were signiﬁcantly impaired
in group III and II compared to group I while LV systolic function parameters by TDI were
impaired signiﬁcantly in group III compared to group I with insigniﬁcant difference by standard
echocardiography.
Conclusion: The increase in LV septal and posterior wall thickness precedes ECG changes. Also LV
diastolic dysfunction and impaired LA active emptying fraction precede LV systolic dysfunction.
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021. Introduction
An important complication of b-thalassemia major is iron
deposition in the cardiac tissue resulting in degeneration, ﬁbro-
sis and dysfunction.1 Cardiac disease is the primary cause of
death.2 Iron-chelation therapy may prevent myocardial dys-gyptian Society of Cardiology.
244 S.Z Sayed et al.function and early death from cardiac disease.3 Despite ade-
quate iron chelation, myocardial function is still worsening
due to iron deposition, ﬁbrosis, and chronic anemia. In clinical
practice, serum ferritin has been used to assess the effectiveness
of treatment. In several studies, diastolic ventricular dysfunc-
tion demonstrated in these patients preceded the onset of sys-
tolic impairment.4 Many of the previous data support
cardiovascular disorders such as structural changes and thick-
nesses of septum and posterior wall and reduction of shorten-
ing fraction and ejection fraction.5 It has been shown that
ventricular wall thickening may be altered by pathologic fac-
tors such as iron deposition. It has been suggested that QT dis-
persion reﬂects regional variation in ventricular recovery.6 It is
an index of inhomogeneity of repolarization. It is usually ex-
pressed as the difference or the range of the various repolariza-
tion measurements obtained from the heart.7 Increased QT
dispersion is a predictor of sudden death and ventricular
arrhythmias in the patients with chronic heart failure.8
2. Aim of the work
To detect the early cardiac involvement in patients with b-thal-
assemia major.
3. Patients and methods
Our study was carried out on 56 patients with b-thalassemia
major who had regular follow up in pediatric hematology out-
patient’s clinic, children university hospital, Al Minia Univer-
sity from February 2009 to April 2011. For the purpose of this
study, severity of iron overload was deﬁned by serum ferritin
level, and patients were classiﬁed accordingly into the follow-
ing three groups:-group I included 21 patients with serum fer-
ritin level <2500 ng/ml, group II included 23 patients with
serum ferritin level 2500–5000 ng/ml and group III included
12 patients with serum ferritin level >5000 ng/ml.
Inclusion criteria:
– Age between 6 and 16 years old.
– Transfusion burden P12/year.9
– Last blood transfusion was less than 4 days ago.
Exclusion criteria:
– Patients younger than 6 years old.
– Transfusion burden <12/year.
– Any cardiac disease e.g. rheumatic, congenital, heart
failure. . .etc.).
The studied groups were subjected to;
Detailed clinical evaluation
Laboratory investigations included complete blood count
by Sysmex and Serum ferritin by ELISA based on a monoclo-
nal antibody sandwich to ensure optimal sensitivity and spec-
iﬁcity (Normal range was 18–323 ng/ml).10
Standard 12-lead electrocardiography (ECG). Heart rate
was calculated from the average RR interval of the tracings.
QT intervals were measured manually in blinded fashion
from the onset of QRS complex to the end of the T wave
on the isoelectric line by the same physician. For each lead,
three consecutive QT intervals were measured and averaged.
QT dispersion (QTd) was deﬁned as the difference betweenthe longest and shortest QT intervals. QT intervals were cor-
rected by heart rate according to Bazett’s formula
(QTc = QT/
p
RR).11
Finally, standard Echocardiography & Tissue Doppler
Imaging (TDI); all examinations were performed in the left lat-
eral decubitus position by using general electric vivid three
ultrasound units equipped with 2.5–3.5 MHz transducers and
a pulsed wave TDI program with simultaneous ECG tracing.
The measurements represent a mean of at least three consecu-
tive cardiac cycles. Doppler parameters of transmitral early
and late diastolic velocities were obtained, then E/A ratio
was calculated. Also deceleration time (DT) was measured.
Septal and posterior wall thickness was measured and ejection
fraction (EF) was obtained by an M-mode approach.12 Left at-
rial (LA) volumes were measured by biplane area-length meth-
od in ml3. LA volume measurements were done at the onset of
atrial systole (LAVp)-P wave at ECG-and at the closure of mi-
tral valve (LAVmin), then LA active emptying fraction was
calculated: LA active emptying fraction = LAVpLAVmin/
LAVp. The pulsed wave Tissue Doppler Imaging (TDI) was
performed by activating the TDI function in the same echo
machine. Two different sites at the mitral annulus were se-
lected in the apical 4-chamber view, the TDI cursor was placed
at the septal side as well as lateral site of the mitral annulus.
Three major velocities were recorded: the positive systolic
velocity (S) and two negative diastolic velocities (one during
the early phase of diastole (Ea) and another in the late phase
of diastole (Aa) (Fig. 1).
Q–S peak was deﬁned as time elapsed from the inscription
of the Q-wave on the surface ECG to the peak of the S-wave
(Fig. 2).13
The peak value of the S-wave and the Q–S peak dura-
tion were taken as determinants of systolic function. E/A
ratio and DT were taken as determinants of diastolic
function.
4. Statistical methodology
Standard computer program SPSS for windows, release 13.0
(SPSS Inc, USA) was used for data entry and analysis. All nu-
meric variables were expressed as mean ± standard deviation
(SD). Comparison of different variables in various groups
was done using student’s t-test and ANOVA test. A signiﬁcant
P value was considered when P value was less than 0.0514
5. Results
The clinical data of the studied group were summarized in (Ta-
ble 1). No statistical signiﬁcant differences were observed be-
tween different groups as regards weight, height, systolic
blood pressure, diastolic blood pressure and heart rate where
(P value > 0.05) Table 2 .
Concerning electrocardiographic ﬁndings, QTc and QTd
intervals were signiﬁcantly increased in group III in compari-
son to group I while group II showed an insigniﬁcant increase
in QTc and QTd compared to group I (Table 3).
There was a signiﬁcant increase in septal wall thickness in
group II and group III compared to group I (P= 0.002,
0.0001), respectively, also there was a signiﬁcant increase in
posterior wall thickness in group II and group III compared
to group I (P= 0.012, 0.001), respectively (Table 3).
Figure 1 Shows TDI of LV lateral wall (systolic and diastolic wave).
Figure 2 Shows TDI of the septum (Q–S duration).
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There was a signiﬁcant increase in E/A ratio in group II and
group III compared to group I. These changes were in both
Standard Echocardiography & Tissue Doppler Imaging results
(Table 4). Deceleration time of mitral ﬂow was signiﬁcantly de-
creased in group III compared to group I while group II
showed an insigniﬁcant decrease in deceleration time com-
pared to group I (Table 4).
As regards systolic function by M mode (EF%, FS%),
there was non-signiﬁcant differences between groups II and
III compared to group I (Table 4). Group III had a signiﬁcant
lower peak S wave (P value = 0.00) and a signiﬁcant prolon-gation of Q–S duration (P value = 0.00) at the sepal wall com-
pared to group I. Tissue Doppler ﬂow results of lateral wall
showed the same behavior (Table 4). Finally, groups III and
II showed a signiﬁcant impairment in left atrial active empty-
ing function compared to group I (P= 0.00 and 0.02, respec-
tively) (Table 4).
7. Discussion
Cardiac involvement represents an important complication of
b-thalassemia major, and results in increased mortality and
morbidity rates. Disease mechanisms implicate iron inﬁltration
of the heart structures due to frequent blood transfusions.
Table 2 Comparison between different groups of b-thalassemic patients as regards some clinical data.
Group I no (21) Group II no (23) Group III no (12) P value
Weight (kg)
Mean ± SD 24.7 ± 16.2 21.8 ± 10.39 21.42 ± 9.28 0.38
Percentile
<5 5 (23.8%) 8 (34.78%) 7 (58.34%)
5–95 16 (76.19%) 15 (65.21%) 5 (41.66%)
>95 0 (0%) 0 (0%) 0 (0%)
Height (cm)
Mean ± SD 137.25 ± 25.4 135.36 ± 15.84 136 ± 11.89 0.45
Percentile
<5 4 (19.04%) 5 (21.73%) 6 (50%)
5–95 16(76.19%) 18 (78.26%) 6 (50%)
>95 1 (4.76%) 0 (0%) 0 (0%)
Systolic BP
(mmHg) 100.25 ± 13.4 104.85 ± 11.88 110.83 ± 6.337 0.26
Mean ± SD
Percentile
5–95 21(100%) 23(100%) 12 (100%)
>95 0 (0%) 0 (0%) 0 (0%)
Diastolic BP
(mmHg)
Mean ± SD 67 ± 8.796 67.08 ± 7.79 73.33 ± 4.924 0.97
Percentile 21 (100%) 23 (100%) 12 (100%)
5–95 0 (0%) 0 (0%) 0 (0%)
>95
Heart Rate
(beat/min)
Range 70–97 75–105 70–120 0.1
Mean ± SD 85.5 ± 17.532 91.79 ± 11.463 99.5 ± 7.574
Table 1 Description of the b-thalassemic patients as regards some clinical data.
Datum Group I with serum
ferritin <2500 ng/ml
Group II with serum ferritin
2500–5000 ng/ml
Group III with serum
ferritin >5000 ng/ml
N (21) N (23) N (12)
Sex
Male: N (%) 12 (57.14%) 12 (52.17%) 12 (52.17%)
Female: N (%) 9 (42.86%) 11 (47.83%) 4 (33.34%)
AGE (years)
Range 6–16 Y 6–12 Y 7–16 Y
Mean ± SD 9.35 ± 4.591 10.5 ± 2.432 12.33 ± 2.934
Age of onset (months)
Range 6–48 6–48 6–18
Mean ± SD 9.52 ± 8.92 8.87 ± 7.97 7.83 ± 4.02
Similar conditions in the
family. N (%)
10 (47.62%) 7 (30.43%) 4 (33.34%)
Consanguinity. N (%)
+ve 6 (28.57%) 8 (34.78%) 4 (33.34%)
ve 15(71.43%) 15 (65.22%) 8 (66.66%)
Residence:
Urban: no (%) 7 (33.34%) 6 (26.08%) 3 (25%)
Rural: no (%) 14 (66.67%) 17 (73.91%) 9 (75%)
Frequency of transfusion/
yr.
Range 12–18 12–24 12–24
Mean ± SD 12.87 ± 2.68 14.48 ± 4.81 17 ± 5.62
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Table 3 Comparison of QTc, QTd, septal and posterior walls in different groups.
Group I Group II Group III P1 P2
QTc ms 366.85 ± 48.24 369.61 ± 25.41 427.01 ± 27.82 0.63 0.00
QTd ms 37.43 ± 11.55 39.32 ± 10.58 44.94 ± 11.66 0.44 0.01
Septal wall thickness mm 5.8 ± 13 5.7 ± 12 6.9 ± 8 0.002 0.0001
Posterior wall thickness mm 5.7 ± 12 6.4 ± 11 6.5 ± 10 0.012 0.001
P1 = II Vs. I, P2 = III Vs. I.
Table 4 Comparison of E/A ratio, deceleration time of mitral valve, systolic function by M mode, TDI and left atrial emptying
function among different groups.
Group I Group II Group III P1 P2
M E/A 1.6 ± 0.28 1.9 ± 0.29 2.25 ± 0.38 0.00 0.00
Septum E/A 1.97 ± 0.13 2.0 ± 0.41 2.49 ± 0.36 0.00 0.00
Lateral wall E/A 1.8 ± 0.57 1.9 ± 0.3 2.6 ± 0.2 0.00 0.00
M DT 150.75 ± 17.15 134.08 ± 21.48 97.5 ± 12.33 0.87 0.00
EF% 66.28 ± 5.53 67.35 ± 5.52 65 ± 4.52 0.13 0.26
FS% 35.52 ± 4.32 36.22 ± 4.6 34.5 ± 2.54 0.19 0.21
Peak S wave cm/s (septum) 8 ± 0.31 6.88 ± 0.44 6.75 ± 0.61 0.09 0.000
Q–S duration ms(septum) 145.23 ± 6.84 160.86 ± 12.28 163 ± 4 0.1 0.000
Peak S wave cm/s (lateral wall) 8.23 ± 0.51 7.06 ± 0.32 6.83 ± 0.1 0.08 0.00
Q–S duration ms(lateral wall) 132.4 ± 4.38 143.86 ± 7.05 145.5 ± 3.9 0.4 0.00
LA active emptying fraction 44.46 ± 3.26 43 ± 5.91 38.38 ± 1.66 0.02 0.00
M=mitral ﬂow, DT = deceleration time, EF%= ejection fraction FS%= fractional shortening, LA-: left atrium, P1 = II Vs. I, P2 = III
Vs. I.
The early cardiac involvement in patients with b-thalassemia major 247Transfusion-dependent patients receive 20 times the normal in-
take of iron, which leads to iron accumulation and damage in
the liver, heart, and endocrine organs.15 Although iron chelat-
ing therapy has markedly improved outcomes, cardiac failure
remains an important cause of death in thalassemic patients.16
We therefore undertook this study to detect the early car-
diac involvement in these patients.
In the current study, QTc was prolonged signiﬁcantly in
thalassemic patients with serum ferritin >5000 ng/ml com-
pared to group I while septal and posterior wall thickness
was increased signiﬁcantly in groups III and II compared to
group I. The increase in LV wall thickness may be explained
by iron deposition in the myocytes causes them to hypertrophy
which may partly contribute to the increased QT dispersion.16
These results were similar to the results obtained by Kocharian
et al., who found a signiﬁcant difference in QT dispersion in
thalassemia major patients and normal persons. QTc was sig-
niﬁcantly broader in LVH+ patients (pts with left ventricular
hypertrophy) compared with LVHpatients (without left ven-
tricular hypertrophy). On the other hand, local ischemia of the
hypertrophied ventricular myocyte may be one potential mech-
anism for the increased dispersion of repolarization and it is
shown that QTa interval (measured from the onset of QRS
to the apex of T wave) tended to be longer in LVH+ patient
as compared with LVH patients. This hypertrophy of myo-
cytes may partly contribute to the increased QT dispersion.17
Some studies showed an increase in the thickness of posterior
wall, dimension of atrium and aortic root and left ventricular
systolic and diastolic dimensions in thalassemic patients. They
can be some reasons of increased QT dispersion in thalassemic
patients.5 Taysir et al., found that the QTc interval and theQTd dispersion were increased in thalassemic patients with
no signiﬁcant difference.18These results are in accordance with
our results in group II that showed insigniﬁcant prolongation
in QTc and QTd compared to group I. The results of Taysir
et al. were in contrast to our results concerning with group
III compared to other groups. This is may be explained by
the difference in serum level of ferritin in group III and with
its level in Taysir et al. study which is not too high to produce
signiﬁcant changes in QTc and QTd intervals.18
As regards diastolic function parameters, the current study
found that diastolic function parameters (E/A ratio and decel-
eration time) were signiﬁcantly impaired in group III by both
standard and TDI. Our results are in accordance with results
of Silvilairat et al.,19Their ﬁndings support the hypothesis that
Pulsed wave Doppler and TDI patterns of LV diastolic dys-
function reﬂect the severity of iron overload in which these
Doppler parameters signiﬁcantly correlated to the serum ferri-
tin as LV diastolic dysfunction was absent in all patients with
serum ferritin <2500 ng/mL and was present in all patients
with serum ferritin >5000 ng/mL. These changes were signiﬁ-
cantly correlated to the serum ferritin.19 Olivieri et al., reported
that the cardiovascular prognosis in patients with homozygous
b thalassemia was excellent if serum ferritin was below
2500 ng/mL.1 Spirito and colleagues, reported a restrictive pat-
tern of transmitral ﬂow in a group of young adults with nor-
mal systolic function and no alteration in left ventricular
compliance was reported in the early stage of the disease.20
The results of Ghaemian et al., study indicate that the mea-
surement of diastolic ﬁlling parameters is a sensitive noninva-
sive method for identifying cardiac involvement in patients
with thalassemia major when symptoms of heart failure are ab-
248 S.Z Sayed et al.sent and systolic function is normal. This technique may be
useful in providing a therapeutic guide to assess the efﬁcacy
of iron removal therapy.21
As regards systolic function, the current study found that
there was an insigniﬁcant difference between the different
groups as regards LV systolic function by M mode (EF%)
where P value > 0.05, while by TDI, group III had lower peak
S wave and signiﬁcant prolongation of Q–S duration at the
septum and lateral walls compared to group I. Silvilairat
et al., reported that TDI may be the early detection of systolic
ventricular dysfunction.19
Ucar et al.,22 and Aypar et al.,23 conﬁrmed that TDI seems
to be an early sensitive parameter of cardiac dysfunction in
thalassemic patients.
However, Bosi et al., found a weak but signiﬁcant correla-
tion between left ventricular ejection fraction and serum ferri-
tin concentration, where patients with a high ferritin
concentration (>2500 ng/ml) had a lower ejection fraction
than patients with a low ferritin concentration (<1000 ng/
ml).24 The higher mean age of the patients in Bosi’s study
might be the responsible factor for the detection of changes
in LV systolic function by M mode echocardiography as well
as by TDI. Also, Wood et al., found that cardiac risk is con-
veyed by positive iron balance over a prolonged period of
time.25 Magri et al., reported that even in a population of
young, asymptomatic and well-chelated patients with thalasse-
mia major, there is an impairment of myocardial function and
that this condition could be easily detected by more advanced
ultrasound techniques such as TDI.26
Concerning left atrial emptying function, our study re-
vealed that left atrial emptying function was impaired in
groups III and II compared to group I. Arbab-Zadeh et al., re-
ported that diastolic dysfunction precedes systolic function in
many systemic diseases and leads to left atrial dilation and im-
paired atrial contraction.27 In addition to that, Trikas et al.,
have illustrated that LAEF was reduced in well-preserved thal-
assemic patients, this reduction was associated with reduced
exercise capacity.28 Walter et al., postulated that left atrial
dilation and dysfunction would be earlier markers of iron car-
diotoxicity than depressed ventricular function in thalassemia
major subjects, and that LA ejection fraction (EF) was a more
sensitive marker of cardiotoxicity than left ventricular ejection
fraction (LVEF).29 Also Walter demonstrated that atrial vol-
ume and function were decreased by cardiac iron overload.
Decreased atrial ejection fraction probably represents a combi-
nation of increased atrial afterload (through ventricular stiff-
ening) as well as direct poisoning of the atrial muscle.29
Autopsy studies suggested greater iron deposition in the ventri-
cles, compared with the atria, but the thin walls and relative
muscular paucity of the left atrium may make it more vulner-
able to even small amounts of tissue iron.30 Regardless of the
mechanisms, depressed left atrial ejection fraction was 2.5–
3.5 times more sensitive than depressed ventricular ejection
fraction in identifying subjects with heavy cardiac iron bur-
den.29 Therefore, atrial ejection fraction may serve as a valu-
able marker of pre-clinical cardiac dysfunction in the
developing world; this is in accordance with Shabanian
et al., who found that combining the atrial ejection force with
the transmitral-derived echocardiographic assessment is a fea-
sible way to detect early stages of myocardial iron overload in
patients with beta thalassemia major.318. Conclusion
The increase in LV septal and posterior wall thickness precedes
changes in QTc and QTd as precursors of arrhythmias. Also
the decrease in LA active emptying fraction as well as LV dia-
stolic dysfunction precede changes in LV systolic function.
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